L&S Knock-Out Teva Pharmaceutical.../ DE000LX3R395 /
03/06/2024 8:48:04 | Diferencia-0.02 | Bid8:48:04 | Ask8:48:04 | Subyacente | Precio de ejercicio | Fecha de expiración | Tipo de opción |
---|---|---|---|---|---|---|---|
0.67EUR | -2.90% | 0.67 Volumen de oferta: - |
0.68 Tamaño/ Volumen/ Formato de Ask: - |
- | 9.00 EUR | 12/06/2024 | Call |
GlobeNewswire
8:30
Orion is developing the Finnish life science industry in a unique collaboration project
GlobeNewswire
8:01
Flash News: OKX Announces Adjustments to Minimum Order Quantities for Select Futures Listings
GlobeNewswire
8:00
FTI Consulting Adds Senior Chemicals Industry Expert to Further Expand Business Transformation Pract...
GlobeNewswire
8:00
Caledonia to file preliminary economic assessment on chosen approach to develop the Bilboes sulphide...
GlobeNewswire
8:00
QIAGEN expands QIAstat-Dx syndromic testing menu in the U.S. with launch of molecular test to improv...
GlobeNewswire
7:48
Flash News: OKX Announces Enhancements to Portfolio Margin Mode to Optimize Trading Experience
GlobeNewswire
7:30
Vallourec: Andre Lacerda Appointed Senior Vice President of South America (Tubes Activities)
GlobeNewswire
7:30
Transgene - First Patient Enrolled in Phase II Part of Randomized Phase I/II Trial Evaluating Lead C...
- Primera página
- Atrás
- 1
- 2
- 3
- 4
- Siguiente
- Última página